Susanne Irene Scott
Research Subjects
Susanne Irene Scott has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Christian von Buchwald
Department of Otorhinolaryngology, Head and Neck Surgery and Audiology Rigshospitalet, University of Copenhagen Copenhagen Denmark
7 shared publications - Henrik Kehlet
Section for Surgical Pathophysiology, Rigshospitalet, Copenhagen University , Copenhagen
4 shared publications Anne Kathrine Østergaard Madsen
Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Copenhagen University Hospital Copenhagen, Rigshospitalet, Denmark
2 shared publicationsClaus V. Jensen
Department of Diagnostic Radiology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark
2 shared publications- Irene Wessel
Clinical Nutrition Center, Department of Transplantation and Digestive Diseases, Rigshospitalet, Copenhagen, Denmark
2 shared publications Niclas Rubek
Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark
2 shared publications
Latest Publications
- Open Access
- 21 June 2026
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 146 (10) , 1-9
The minimal clinically important difference for the Sniffin’ Sticks Identification Test-16 in patients with chronic rhinosinusitis with nasal polyps treated with biologics
The Minimal Clinically Important Difference (MCID) reflects the smallest change in a test score perceived as relevant by the patient. MCIDs vary according to disease and clinical context. The Sniffin' Sticks Identification Test 16 (SSIT-16) is a commonly used smell assessment tool, but its MCID in severe chronic rhinosinusitis with nasal polyps (CRSwNP) is unknown. To determine the MCID of SSIT-16 in severe CRSwNP treated with biologics. We analysed change scores from baseline to week 24 in 313 patients. The MCID was estimated using anchor-based and distribution-based methods. Anchors included a visual analogue scale (VAS) for smell, the rhinologic domain of SNOT-22, and the smell/taste item of SNOT-22. Distribution-based analyses included half a standard deviation of baseline SSIT-16 scores, the standard error of measurement (SEM), and the individual-level smallest detectable change. The smell VAS performed best and was therefore chosen as the primary anchor. The optimal ΔSSIT-16 cut-off, balancing sensitivity (78%) and specificity (84%), was 3.5 points. This estimate was supported by distribution-based, sensitivity, and subgroup analyses. An improvement of approximately 3.5 SSIT-16 points appears to reflect clinically meaningful change in biologically treated patients with severe CRSwNP and may serve as a pragmatic threshold for interpreting olfactory outcomes.
- 21 June 2026
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 146 (10) , 1-9
Open AccessThe minimal clinically important difference for the Sniffin’ Sticks Identification Test-16 in patients with chronic rhinosinusitis with nasal polyps treated with biologics
The Minimal Clinically Important Difference (MCID) reflects the smallest change in a test score perceived as relevant by the patient. MCIDs vary according to disease and clinical context. The Sniffin' Sticks Identification Test 16 (SSIT-16) is a commonly used smell assessment tool, but its MCID in severe chronic rhinosinusitis with nasal polyps (CRSwNP) is unknown. To determine the MCID of SSIT-16 in severe CRSwNP treated with biologics. We analysed change scores from baseline to week 24 in 313 patients. The MCID was estimated using anchor-based and distribution-based methods. Anchors included a visual analogue scale (VAS) for smell, the rhinologic domain of SNOT-22, and the smell/taste item of SNOT-22. Distribution-based analyses included half a standard deviation of baseline SSIT-16 scores, the standard error of measurement (SEM), and the individual-level smallest detectable change. The smell VAS performed best and was therefore chosen as the primary anchor. The optimal ΔSSIT-16 cut-off, balancing sensitivity (78%) and specificity (84%), was 3.5 points. This estimate was supported by distribution-based, sensitivity, and subgroup analyses. An improvement of approximately 3.5 SSIT-16 points appears to reflect clinically meaningful change in biologically treated patients with severe CRSwNP and may serve as a pragmatic threshold for interpreting olfactory outcomes.
- Open Access
- 14 October 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (8) , 1893-1898
Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy
Objective(s): To investigate dysphagia and quality of life (QoL) outcomes 3 years after treatment of oropharyngeal cancer with either primary trans oral robotic surgery (TORS) or radiotherapy (RT).Methods: A prospective cohort study conducted at the Copenhagen University Hospital. Endpoints were objective swallowing function, examined using fiberoptic endoscopic evaluation of swallowing (FEES) and video fluoroscopy (VF). QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ‐C30), Head & Neck Module (EORTC QLQ‐HN35), and MD Anderson Dysphagia Inventory (MDADI). A comparison was made between 1‐, and 3‐year results.Results: Forty‐four patients were included prior to treatment, 31 treated with TORS and 13 with RT. One‐year results for this cohort have previously been published (https://doi.org/10.1080/00016489.2020.1836395). Significant improvement on FEES in retention at the piriform sinus was noted in both groups. Patients treated with TORS had improved safety scores as well as dynamic imaging grade of swallowing toxicity (DIGEST) and efficiency scores, whereas patients treated with RT only had improvements in the latter two. Improvement in QoL scores was only noted for patients treated with TORS in composite MDADI scores.Conclusion: We found significant improvements in objective swallowing function from one to 3 years after treatment, particularly in patients treated with TORS. However, these improvements were not reflected as clinically meaningful improvements in QoL.Level of Evidence: 3, cohort follow‐up study Laryngoscope, 133:1893–1898, 2023
- 14 October 2022
- Published by Wiley in The Laryngoscope
- Vol. 133 (8) , 1893-1898
Open AccessDysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy
Objective(s): To investigate dysphagia and quality of life (QoL) outcomes 3 years after treatment of oropharyngeal cancer with either primary trans oral robotic surgery (TORS) or radiotherapy (RT).Methods: A prospective cohort study conducted at the Copenhagen University Hospital. Endpoints were objective swallowing function, examined using fiberoptic endoscopic evaluation of swallowing (FEES) and video fluoroscopy (VF). QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ‐C30), Head & Neck Module (EORTC QLQ‐HN35), and MD Anderson Dysphagia Inventory (MDADI). A comparison was made between 1‐, and 3‐year results.Results: Forty‐four patients were included prior to treatment, 31 treated with TORS and 13 with RT. One‐year results for this cohort have previously been published (https://doi.org/10.1080/00016489.2020.1836395). Significant improvement on FEES in retention at the piriform sinus was noted in both groups. Patients treated with TORS had improved safety scores as well as dynamic imaging grade of swallowing toxicity (DIGEST) and efficiency scores, whereas patients treated with RT only had improvements in the latter two. Improvement in QoL scores was only noted for patients treated with TORS in composite MDADI scores.Conclusion: We found significant improvements in objective swallowing function from one to 3 years after treatment, particularly in patients treated with TORS. However, these improvements were not reflected as clinically meaningful improvements in QoL.Level of Evidence: 3, cohort follow‐up study Laryngoscope, 133:1893–1898, 2023
- 5 April 2021
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 141 (6) , 646-648
Danish translation of the Neck Dissection Impairment Index
Shoulder pain and impairment are known complications to neck dissections (NDs) as part of the surgical management of head and neck cancer (HNC). The Neck Dissection Impairment Index (NDII) is a val... 背景:肩部疼痛和损伤是已知的头颈癌(ND)并发症。颈部解剖是头颈癌(HNC)外科手术治疗的一部分。颈部解剖损伤指数(NDII)是一种经过验证的与肩膀功能相关的生活质量指标, 是患者报告的头颈手术结果的重要指标。将问卷正确翻译成其他语言对于患者的个人评估和未来研究都非常重要。目的:将NDII译成丹麦文。方法:使用正向和反向翻译程序将NDII从英语翻译成丹麦语。对翻译后的调查问卷的准最终版本进行...
- 5 April 2021
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 141 (6) , 646-648
Danish translation of the Neck Dissection Impairment Index
Shoulder pain and impairment are known complications to neck dissections (NDs) as part of the surgical management of head and neck cancer (HNC). The Neck Dissection Impairment Index (NDII) is a val... 背景:肩部疼痛和损伤是已知的头颈癌(ND)并发症。颈部解剖是头颈癌(HNC)外科手术治疗的一部分。颈部解剖损伤指数(NDII)是一种经过验证的与肩膀功能相关的生活质量指标, 是患者报告的头颈手术结果的重要指标。将问卷正确翻译成其他语言对于患者的个人评估和未来研究都非常重要。目的:将NDII译成丹麦文。方法:使用正向和反向翻译程序将NDII从英语翻译成丹麦语。对翻译后的调查问卷的准最终版本进行...
- Open Access
- 4 December 2020
- Published by Wiley in Cancer Medicine
- Vol. 10 (2) , 483-495
Long‐term quality of life & functional outcomes after treatment of oropharyngeal cancer
Functional and QoL outcomes were compared longitudinally in a cohort of patients treated for oropharyngeal squamous cell carcinoma (OPSCC) with primary transoral robotic surgery (TORS) or radiotherapy (RT). Forty‐four patients undergoing primary TORS (n = 31) or RT (n = 13) for any stage OPSCC were included. Only low‐stage disease was treated with TORS. Functional outcomes were: salivary flow rate, image‐based swallowing function, and a self‐reported 10‐point scale comparing current swallowing function to baseline (CvB scale). QoL was assessed with European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ‐C30), Head & Neck Module (EORTC QLQ‐HN35), and MD Anderson Dysphagia Inventory (MDADI). Shoulder impairment was assessed with Neck Dissection Impairment Index (NDII) and Oxford Shoulder Score (OSS). In the RT group, salivary flow rates had significantly declined at 12‐month follow‐up, with the biggest declines in QoL subscale scores recorded in the RT group for dry mouth and sticky saliva. Swallowing function on imaging studies was overall good, with no severe dysphagia within 1 year although, both treatment groups showed significant deterioration relative to baseline at the 12‐month follow‐up with increased DIGEST scores and pharyngeal retention. Shoulder impairment was rare at 1 year in both groups. A comprehensive examination of this cohort treated for OPSCC showed overall good functional and QoL outcomes 1 year after treatment. However, persistent impairment was seen in both groups with regards to swallowing function. In the TORS group, at 12‐months follow‐up, the QoL questionnaires showed worse scores in only one subscale (sticky saliva).
- 4 December 2020
- Published by Wiley in Cancer Medicine
- Vol. 10 (2) , 483-495
Open AccessLong‐term quality of life & functional outcomes after treatment of oropharyngeal cancer
Functional and QoL outcomes were compared longitudinally in a cohort of patients treated for oropharyngeal squamous cell carcinoma (OPSCC) with primary transoral robotic surgery (TORS) or radiotherapy (RT). Forty‐four patients undergoing primary TORS (n = 31) or RT (n = 13) for any stage OPSCC were included. Only low‐stage disease was treated with TORS. Functional outcomes were: salivary flow rate, image‐based swallowing function, and a self‐reported 10‐point scale comparing current swallowing function to baseline (CvB scale). QoL was assessed with European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ‐C30), Head & Neck Module (EORTC QLQ‐HN35), and MD Anderson Dysphagia Inventory (MDADI). Shoulder impairment was assessed with Neck Dissection Impairment Index (NDII) and Oxford Shoulder Score (OSS). In the RT group, salivary flow rates had significantly declined at 12‐month follow‐up, with the biggest declines in QoL subscale scores recorded in the RT group for dry mouth and sticky saliva. Swallowing function on imaging studies was overall good, with no severe dysphagia within 1 year although, both treatment groups showed significant deterioration relative to baseline at the 12‐month follow‐up with increased DIGEST scores and pharyngeal retention. Shoulder impairment was rare at 1 year in both groups. A comprehensive examination of this cohort treated for OPSCC showed overall good functional and QoL outcomes 1 year after treatment. However, persistent impairment was seen in both groups with regards to swallowing function. In the TORS group, at 12‐months follow‐up, the QoL questionnaires showed worse scores in only one subscale (sticky saliva).
- 5 November 2020
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 141 (2) , 193-196
Days alive and out of hospital after treatment for oropharyngeal squamous cell carcinoma with primary transoral robotic surgery or radiotherapy – a prospective cohort study
Background With the rising incidence of oropharyngeal squamous cell cancer, there is a need to assess the burden of treatment. Aims/objectives This study assessed 'days alive and out of hospital' (DAOH) in a cohort of patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with either transoral robotic surgery (TORS) or radiotherapy (RT). Material and methods A prospective cohort study conducted between May 2017-June 2019. Primary outcome was DAOH in the first 30 days after treatment (DAOH(30)). The secondary outcome was DAOH(180). Results Forty-four patients were included, 31 treated with TORS and 13 with RT. Patients treated with TORS had a median DAOH(30) of 25 (IQR 22.8-26) including a required four-day postoperative stay- and a median DAOH(180) of 168 (IQR 163-171.3). In contrast, patients treated with RT had a median DAOH(30) of 30 (IQR 26-30) and a DAOH(180) of 143 days (IQR 135.5-149). Conclusions and Significance DAOH has not been examined in oropharyngeal cancer before. We found, patients overall spent 92.5% of the first 180 days alive and out of hospital. Patients treated with TORS had high DAOH(30), which remained high in DAOH(180), while patients treated with RT with reduced DAOH(30), had reduced DAOH(180) calling for further large-scale studies.
- 5 November 2020
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 141 (2) , 193-196
Days alive and out of hospital after treatment for oropharyngeal squamous cell carcinoma with primary transoral robotic surgery or radiotherapy – a prospective cohort study
Background With the rising incidence of oropharyngeal squamous cell cancer, there is a need to assess the burden of treatment. Aims/objectives This study assessed 'days alive and out of hospital' (DAOH) in a cohort of patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with either transoral robotic surgery (TORS) or radiotherapy (RT). Material and methods A prospective cohort study conducted between May 2017-June 2019. Primary outcome was DAOH in the first 30 days after treatment (DAOH(30)). The secondary outcome was DAOH(180). Results Forty-four patients were included, 31 treated with TORS and 13 with RT. Patients treated with TORS had a median DAOH(30) of 25 (IQR 22.8-26) including a required four-day postoperative stay- and a median DAOH(180) of 168 (IQR 163-171.3). In contrast, patients treated with RT had a median DAOH(30) of 30 (IQR 26-30) and a DAOH(180) of 143 days (IQR 135.5-149). Conclusions and Significance DAOH has not been examined in oropharyngeal cancer before. We found, patients overall spent 92.5% of the first 180 days alive and out of hospital. Patients treated with TORS had high DAOH(30), which remained high in DAOH(180), while patients treated with RT with reduced DAOH(30), had reduced DAOH(180) calling for further large-scale studies.
- 27 October 2020
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 141 (1) , 95-98
Days alive and out of hospital a validated patient-centred outcome to be used for patients undergoing transoral robotic surgery: protocol and perspectives
Days Alive and Out of Hospital (DAOH) has been validated as a suitable clinical trial outcome. It can be used as a proxy for surgical quality and reflects both procedure specific morbidity and mort... 背景:存活并出院的天数(DAOH)已被确认为合适的临床试验结果。它可以用作手术质量的指标, 并反映特定手术的发病率和死亡率。目的:我们建议DAOH可作为已建立的与患者相关的结果及客观结果的补充, 因为它可以增添有关医疗负担的信息。已计划了两项即将进行的与DAOH相关的研究, 并为经口机器人手术的患者报告DAOH。方法:首先, 已计划一项多中心国家前瞻性队列研究对DAOH进行调查, 并在TOR...
- 27 October 2020
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 141 (1) , 95-98
Days alive and out of hospital a validated patient-centred outcome to be used for patients undergoing transoral robotic surgery: protocol and perspectives
Days Alive and Out of Hospital (DAOH) has been validated as a suitable clinical trial outcome. It can be used as a proxy for surgical quality and reflects both procedure specific morbidity and mort... 背景:存活并出院的天数(DAOH)已被确认为合适的临床试验结果。它可以用作手术质量的指标, 并反映特定手术的发病率和死亡率。目的:我们建议DAOH可作为已建立的与患者相关的结果及客观结果的补充, 因为它可以增添有关医疗负担的信息。已计划了两项即将进行的与DAOH相关的研究, 并为经口机器人手术的患者报告DAOH。方法:首先, 已计划一项多中心国家前瞻性队列研究对DAOH进行调查, 并在TOR...
- 28 July 2020
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 16 (5) , 1-10
Design and validation of a cross‐specialty simulation‐based training course in basic robotic surgical skills
Background: The aim of this study was to design and validate a cross‐specialty basic robotic surgical skills training program on the RobotiX Mentor virtual reality simulator.Methods: A Delphi panel reached consensus on six modules to include in the training program. Validity evidence was collected according to Messick's framework with three performances in each simulator module by 11 experienced robotic surgeons and 11 residents without robotic surgical experience.Results: For five of the six modules, a compound metrics‐based score could significantly discriminate between the performances of novices and experienced robotic surgeons. Pass/fail levels were established, resulting in very few novices passing in their first attempt.Conclusions: This validated course can be used for structured simulation‐based basic robotic surgical skills training within a mastery learning framework where the individual trainee can practice each module until they achieve proficiency and can continue training on other modalities and more specific to their specialty.
- 28 July 2020
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 16 (5) , 1-10
Design and validation of a cross‐specialty simulation‐based training course in basic robotic surgical skills
Background: The aim of this study was to design and validate a cross‐specialty basic robotic surgical skills training program on the RobotiX Mentor virtual reality simulator.Methods: A Delphi panel reached consensus on six modules to include in the training program. Validity evidence was collected according to Messick's framework with three performances in each simulator module by 11 experienced robotic surgeons and 11 residents without robotic surgical experience.Results: For five of the six modules, a compound metrics‐based score could significantly discriminate between the performances of novices and experienced robotic surgeons. Pass/fail levels were established, resulting in very few novices passing in their first attempt.Conclusions: This validated course can be used for structured simulation‐based basic robotic surgical skills training within a mastery learning framework where the individual trainee can practice each module until they achieve proficiency and can continue training on other modalities and more specific to their specialty.
- 9 May 2018
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 138 (9) , 837-842
Time course of subacute pain after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma versus traditional bilateral tonsillectomy in adults – a case–control study
To examine pain after Transoral Robotic Surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC) versus traditional bilateral tonsillectomy in adults. Pain evolvement was assessed in a prospective case-control design of 16 consecutive patients treated with TORS for early stage OPSCC versus 12 patients, who underwent bilateral tonsillectomy on suspicion of malignant disease. The TORS group received an optimized analgesia regime of preoperative oral celecoxib and gabapentin, intra- and postoperative high-dose intravenous dexamethasone, and regular postoperative oral contalgin, gabapentin, celecoxib, paracetamol and rescue morphine. The tonsillectomy group received the departmental standard analgesia regime with low-dose preoperative oral dexamethasone, celecoxib and paracetamol. Postoperative regular analgesia consisted of oral NSAID and paracetamol with weak opioids prescribed as required. Pain intensity was recorded at rest and during swallowing twice a day. The median pain intensity on postoperative day (POD) 1-4 was 2 in the TORS group versus 4.5 in the tonsillectomy group. From POD 5-10 median pain intensity was 3.5 and 4, respectively. The median length of stay was 5 days in the TORS group and less than 24 hours in the tonsillectomy group. With an optimized analgesia regime TORS for OPSCC can be performed with postoperative pain levels comparable to bilateral tonsillectomy in adults.
- 9 May 2018
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 138 (9) , 837-842
Time course of subacute pain after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma versus traditional bilateral tonsillectomy in adults – a case–control study
To examine pain after Transoral Robotic Surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC) versus traditional bilateral tonsillectomy in adults. Pain evolvement was assessed in a prospective case-control design of 16 consecutive patients treated with TORS for early stage OPSCC versus 12 patients, who underwent bilateral tonsillectomy on suspicion of malignant disease. The TORS group received an optimized analgesia regime of preoperative oral celecoxib and gabapentin, intra- and postoperative high-dose intravenous dexamethasone, and regular postoperative oral contalgin, gabapentin, celecoxib, paracetamol and rescue morphine. The tonsillectomy group received the departmental standard analgesia regime with low-dose preoperative oral dexamethasone, celecoxib and paracetamol. Postoperative regular analgesia consisted of oral NSAID and paracetamol with weak opioids prescribed as required. Pain intensity was recorded at rest and during swallowing twice a day. The median pain intensity on postoperative day (POD) 1-4 was 2 in the TORS group versus 4.5 in the tonsillectomy group. From POD 5-10 median pain intensity was 3.5 and 4, respectively. The median length of stay was 5 days in the TORS group and less than 24 hours in the tonsillectomy group. With an optimized analgesia regime TORS for OPSCC can be performed with postoperative pain levels comparable to bilateral tonsillectomy in adults.
- Open Access
- 1 January 2015
- Published by Edorium Journals Pvt. Ltd. in International Journal of Case Reports and Images
- Vol. 6 (9) , 570-573
An unusual presentation of an incisional ventral wall hernia: A case report
Abdominal incisional herniae are well known complications after abdominal surgery and many methods for repair of the hernial defect have been tried and developed. These include open repair with or without mesh and laparoscopic repair. Case Report: We present an extremely unusual case where the hernia sac had dissected a plane between the anterior sheath and the rectus muscles. Surgical development of this plane is associated with great risk of damage to nerves and vessels and therefore not commonly used in hernia repairs. Conclusion: In this highly unusual case where traditional mesh placement was of little value, we chose a unique and as yet undescribed method of retro-anterior sheath mesh placement with good results at third month.
- 1 January 2015
- Published by Edorium Journals Pvt. Ltd. in International Journal of Case Reports and Images
- Vol. 6 (9) , 570-573
Open AccessAn unusual presentation of an incisional ventral wall hernia: A case report
Abdominal incisional herniae are well known complications after abdominal surgery and many methods for repair of the hernial defect have been tried and developed. These include open repair with or without mesh and laparoscopic repair. Case Report: We present an extremely unusual case where the hernia sac had dissected a plane between the anterior sheath and the rectus muscles. Surgical development of this plane is associated with great risk of damage to nerves and vessels and therefore not commonly used in hernia repairs. Conclusion: In this highly unusual case where traditional mesh placement was of little value, we chose a unique and as yet undescribed method of retro-anterior sheath mesh placement with good results at third month.